laitimes

Chen Yihan, the president of Shanghai Oriental Hospital, discovered the first human atrial fibrillation pathogenic gene

Chen Yihan, the president of Shanghai Oriental Hospital, discovered the first human atrial fibrillation pathogenic gene

Comrade Chen Yihan made a statement. The pictures in this article are from the "Shanghai Oriental Hospital" WeChat public account

On January 14, the "Shanghai Oriental Hospital" WeChat public account revealed: On the afternoon of January 12, Shanghai Oriental Hospital (Oriental Hospital Affiliated to Tongji University) held a cadre announcement meeting and appointed Comrade Chen Yihan as the president of Oriental Hospital.

Chen Yihan, the president of Shanghai Oriental Hospital, discovered the first human atrial fibrillation pathogenic gene

Chen Yihan

Chen Yihan is a cardiologist. In 1996, he graduated from Shanghai Jiao Tong University School of Medicine with a Doctorate in Internal Medicine. Professor, chief physician and doctoral supervisor of Tongji University. He is an academician of the Chinese Academy of Sciences, a member of the Faculty of the Chinese Academy of Medical Sciences, and a member of the Science and Technology Committee of the Ministry of Education He is a member of the National Committee of the Chinese People's Political Consultative Conference, a member of the Central Committee of the Jiusan Society, and a vice chairman of the Shanghai Municipal Committee of the Jiusan Society.

Since 2010, he has also served as the vice president of the Oriental Hospital Affiliated to Tongji University. He is currently the Vice President of Tongji University, the President of The Oriental Hospital Affiliated to Tongji University, the Director of the Department of Cardiology of the Oriental Hospital Affiliated to Tongji University, and the Director of the Key Laboratory of Arrhythmias of the Ministry of Education. He is the winner of the National Science Foundation for Outstanding Young Scholars, the Jiang Scholar Distinguished Professor of the Ministry of Education, the project leader of the Basic Science Center of the National Foundation of China, the project leader of the Innovative Research Group of the National Foundation of China, the person in charge of the National Stem Cell and Major Disease Discipline Innovation Introduction Base, and the project leader of the Innovation Team of the Ministry of Education.

Chen Yihan has long been engaged in clinical work and basic research on cardiovascular diseases, and has made some important scientific discoveries in the field of cardiovascular disease research. He was the first discoverer of the human atrial fibrillation pathogenic gene, he defined the glutamatergic neuron-like cell properties of cardiac pacemakers, discovered a new cardiac bioelectric control system, identified a key signaling pathway that controls myocardial cell proliferation and myocardial regeneration, and developed a series of new drug prodrugs targeting major heart diseases. His scientific discoveries have been rated as the annual breakthrough in the field of cardiac electrophysiology, the top ten scientific and technological progress of Chinese colleges and universities, the second prize of the National Natural Science Award, the first prize of the Natural Science Award of the Ministry of Education, and the first prize of the Shanghai Natural Science Award.

At the same time, he is also the winner of the China Youth Science and Technology Award, the winner of the Chinese Physician Award, the young and middle-aged experts with outstanding contributions of the former Ministry of Health, the scientific and technological elite of Shanghai, the leading talents of Shanghai, the winner of the Peony Award of Natural Science of Shanghai, the winner of the Shanghai Medical Development Outstanding Contribution Award, the Shanghai Model Worker and the winner of the National "May Day Labor Medal".

Read on